JP2009512635A5 - - Google Patents

Download PDF

Info

Publication number
JP2009512635A5
JP2009512635A5 JP2008532866A JP2008532866A JP2009512635A5 JP 2009512635 A5 JP2009512635 A5 JP 2009512635A5 JP 2008532866 A JP2008532866 A JP 2008532866A JP 2008532866 A JP2008532866 A JP 2008532866A JP 2009512635 A5 JP2009512635 A5 JP 2009512635A5
Authority
JP
Japan
Prior art keywords
group
formula
compound
convertible
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008532866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009512635A (ja
JP5209480B2 (ja
Filing date
Publication date
Priority claimed from GBGB0519950.0A external-priority patent/GB0519950D0/en
Priority claimed from GB0602040A external-priority patent/GB0602040D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/003590 external-priority patent/WO2007036715A2/en
Publication of JP2009512635A publication Critical patent/JP2009512635A/ja
Publication of JP2009512635A5 publication Critical patent/JP2009512635A5/ja
Application granted granted Critical
Publication of JP5209480B2 publication Critical patent/JP5209480B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008532866A 2005-09-30 2006-09-27 M1受容体にて活性を有する化合物および医薬におけるそれらの使用 Expired - Fee Related JP5209480B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0519950.0A GB0519950D0 (en) 2005-09-30 2005-09-30 Compounds
GB0519950.0 2005-09-30
GB0602040.8 2006-02-01
GB0602040A GB0602040D0 (en) 2006-02-01 2006-02-01 Compounds
PCT/GB2006/003590 WO2007036715A2 (en) 2005-09-30 2006-09-27 Compounds which have activity at m1 receptor and their uses in medicine

Publications (3)

Publication Number Publication Date
JP2009512635A JP2009512635A (ja) 2009-03-26
JP2009512635A5 true JP2009512635A5 (cg-RX-API-DMAC7.html) 2009-11-12
JP5209480B2 JP5209480B2 (ja) 2013-06-12

Family

ID=37598231

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532866A Expired - Fee Related JP5209480B2 (ja) 2005-09-30 2006-09-27 M1受容体にて活性を有する化合物および医薬におけるそれらの使用

Country Status (24)

Country Link
US (2) US8283364B2 (cg-RX-API-DMAC7.html)
EP (1) EP1943230B1 (cg-RX-API-DMAC7.html)
JP (1) JP5209480B2 (cg-RX-API-DMAC7.html)
KR (2) KR101374458B1 (cg-RX-API-DMAC7.html)
CN (1) CN101321736B (cg-RX-API-DMAC7.html)
AR (1) AR056103A1 (cg-RX-API-DMAC7.html)
AT (1) ATE492537T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006296369B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0616609A2 (cg-RX-API-DMAC7.html)
CA (1) CA2624504C (cg-RX-API-DMAC7.html)
CR (1) CR9904A (cg-RX-API-DMAC7.html)
DE (1) DE602006019119D1 (cg-RX-API-DMAC7.html)
EA (1) EA016286B1 (cg-RX-API-DMAC7.html)
IL (1) IL190219A (cg-RX-API-DMAC7.html)
JO (1) JO2634B1 (cg-RX-API-DMAC7.html)
MA (1) MA29849B1 (cg-RX-API-DMAC7.html)
MY (1) MY148504A (cg-RX-API-DMAC7.html)
NO (1) NO20081945L (cg-RX-API-DMAC7.html)
NZ (1) NZ566508A (cg-RX-API-DMAC7.html)
PE (1) PE20070490A1 (cg-RX-API-DMAC7.html)
TW (1) TWI389905B (cg-RX-API-DMAC7.html)
UA (1) UA101299C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007036715A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200802167B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1960389B1 (en) 2005-09-30 2012-08-15 Glaxo Group Limited Compounds which have activity at m1 receptor and their uses in medicine
WO2007036711A1 (en) 2005-09-30 2007-04-05 Glaxo Group Limited BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR
EA016286B1 (ru) 2005-09-30 2012-03-30 Глэксо Груп Лимитед Соединения, которые обладают активностью по отношению к рецепторам м, и их применения в медицине
US7766829B2 (en) * 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
GB0605785D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0706165D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706174D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706170D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706164D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0718415D0 (en) * 2007-09-20 2007-10-31 Glaxo Group Ltd Compounds
WO2009124882A1 (en) * 2008-04-09 2009-10-15 H. Lundbeck A/S Novel piperidinyl-1,3-dihydro-benzoimidazol-2-ones as m1 agonists
GB0817982D0 (en) 2008-10-01 2008-11-05 Glaxo Group Ltd Compounds
CA2966594A1 (en) * 2014-11-03 2016-05-12 William Beaumont Hospital Method for treating underactive bladder syndrome
BR112017023200A2 (pt) * 2015-04-29 2018-08-07 Janssen Pharmaceutica Nv compostos de indolona e seu uso como moduladores do receptor de ampa
BR122023023802A2 (pt) 2015-04-29 2023-12-26 Janssen Pharmaceutica Nv Compostos azabenzimidazóis, seu uso como moduladores do receptor de ampa e composições farmacêuticas que os compreendem
WO2017044693A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
CN107673994A (zh) * 2017-04-27 2018-02-09 联化科技股份有限公司 一种芳基甲烷类化合物的制备方法
CN107739342B (zh) * 2017-11-29 2020-01-10 华南理工大学 一种一步合成5-二芳氨基苯并咪唑酮衍生物的方法
CN117049938B (zh) * 2023-06-20 2024-06-14 山东轩德医药科技有限公司 一种6-溴-2,3-二氟甲苯的制备方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3161645A (en) * 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3989707A (en) * 1974-06-21 1976-11-02 Janssen Pharmaceutica N.V. Benzimidazolinone derivatives
US4292321A (en) 1979-05-24 1981-09-29 Warner-Lambert Company 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof
DE3124366A1 (de) * 1981-06-20 1982-12-30 Hoechst Ag, 6000 Frankfurt N-oxacyclyl-alkylpiperidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
DE4040300A1 (de) 1990-12-17 1992-07-02 Leifeld Gmbh & Co Drueckmaschine mit wenigstens einem rollenhalter
JP3916093B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 光学活性イミダゾリジノン誘導体とその製造方法
US5574044A (en) 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
AU701127B2 (en) * 1994-10-27 1999-01-21 Merck & Co., Inc. Muscarine antagonists
AU7478396A (en) 1995-10-31 1997-05-22 Merck & Co., Inc. Muscarine agonists
US5718912A (en) 1996-10-28 1998-02-17 Merck & Co., Inc. Muscarine agonists
US5977134A (en) 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6465484B1 (en) 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
US6162804A (en) 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
WO1999032481A1 (en) 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
ES2223588T3 (es) 1999-10-13 2005-03-01 Banyu Pharmaceutical Co., Ltd. Derivados de imidazolidinona sustituidos.
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
AU2001234705A1 (en) 2000-02-01 2001-08-14 Cor Therapeutics, Inc. Indalone and benzimidazolone inhibitors of factor xa
ATE403431T1 (de) 2001-04-18 2008-08-15 Euro Celtique Sa Benzimidazolon-verbindungen
US7164024B2 (en) 2001-04-20 2007-01-16 Banyu Pharmaceutical Co., Ltd. Benzimidazolone derivatives
WO2004089942A2 (en) * 2001-10-02 2004-10-21 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
US6951849B2 (en) 2001-10-02 2005-10-04 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
RU2288919C2 (ru) 2001-10-02 2006-12-10 Акадиа Фармасьютикалз, Инк. Производные бензимидазолидинона в качестве агентов мускариновых рецепторов
WO2003037890A2 (en) 2001-11-01 2003-05-08 Icagen, Inc. Piperidines
US7566728B2 (en) 2002-03-29 2009-07-28 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
US7279490B2 (en) 2002-06-17 2007-10-09 Merck & Co, Inc. Ophthalmic compositions for treating ocular hypertension
CN1744899A (zh) 2002-12-13 2006-03-08 史密丝克莱恩比彻姆公司 作为ccr5拮抗剂的哌啶衍生物
JP2005102133A (ja) 2003-04-28 2005-04-14 Ricoh Co Ltd 画像形成装置及び宛先情報参照方法
CA2532071A1 (en) 2003-07-23 2005-02-03 Wyeth Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands
PL1664036T3 (pl) 2003-09-03 2012-04-30 Pfizer Związki benzimidazolonu wykazujące działanie agonistyczne względem receptora 5-ht4
CA2586179C (en) 2004-11-02 2011-02-08 Pfizer Inc. Sulfonyl benzimidazole derivatives
US7300947B2 (en) 2005-07-13 2007-11-27 Banyu Pharmaceutical Co., Ltd. N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
WO2007036711A1 (en) 2005-09-30 2007-04-05 Glaxo Group Limited BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR
EA016286B1 (ru) 2005-09-30 2012-03-30 Глэксо Груп Лимитед Соединения, которые обладают активностью по отношению к рецепторам м, и их применения в медицине
EP1960389B1 (en) 2005-09-30 2012-08-15 Glaxo Group Limited Compounds which have activity at m1 receptor and their uses in medicine
US8239995B2 (en) 2006-09-08 2012-08-14 The Gillette Company Toothbrush with multiple bristles states
GB0706190D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706173D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706188D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706164D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706174D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706189D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706165D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706187D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706168D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706167D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706170D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds

Similar Documents

Publication Publication Date Title
AU2023201399B2 (en) Modulators of the integrated stress pathway
JP2009510041A5 (cg-RX-API-DMAC7.html)
JP4357965B2 (ja) メタボトロピックグルタミン酸受容体−5のヘテロアリール置換ピロールモジュレーター
JP5313865B2 (ja) ベンゾイミダゾール化合物およびその医薬用途
JP2009510037A5 (cg-RX-API-DMAC7.html)
JP4299139B2 (ja) 代謝型グルタミン酸受容体−5のヘテロアリール置換トリアゾールモジュレータ
CN100352816C (zh) 伤害感受肽类似物
AU2015335703B2 (en) Carbazole derivatives
CA2624504A1 (en) Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
JP2011500758A5 (cg-RX-API-DMAC7.html)
RU2005104434A (ru) Производные 1-гетероциклилалкил-3-сульфонилиндола или - индазола как лиганды 5-гидрокситриптамина-6
JP2009538910A5 (cg-RX-API-DMAC7.html)
JP2005526081A (ja) 代謝型グルタメート−5の二アリール置換テトラゾールモジュレータ
JP2009530348A5 (cg-RX-API-DMAC7.html)
WO2017049462A1 (zh) 一类新型的flt3激酶抑制剂及其用途
CN114364685A (zh) 含氮杂环类化合物,及其制备方法、药物组合物和应用
JP2006522137A (ja) 代謝型グルタミン酸受容体−5のジ−アリール置換ピロールモジュレーター
JP5209481B2 (ja) M1受容体にて活性を有する化合物および医薬におけるそれらの使用
JP2012507525A5 (cg-RX-API-DMAC7.html)
WO2004087653A2 (en) 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
CN1277611A (zh) 3-取代的四氢吡啶并嘧啶酮衍生物,它们的制备方法和应用
JP2009513513A (ja) Orl−1受容体リガンドとしての置換インドール
JP2013510814A5 (cg-RX-API-DMAC7.html)
JP2010527370A5 (cg-RX-API-DMAC7.html)
RU2451017C2 (ru) Бензимидазольное соединение и его фармацевтическое применение